Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Wieske, Luukvan Dam, Koos P J
Steenhuis, Maurice
Stalman, Eileen W
Kummer, Laura Y L
van Kempen, Zoé L E
Killestein, Joep
Volkers, Adriaan G
Tas, Sander W
Boekel, Laura
Wolbink, Gerrit J
van der Kooi, Anneke J
Raaphorst, Joost
Löwenberg, Mark
Takkenberg, R Bart
D'Haens, Geert R A M
Spuls, Phyllis I
Bekkenk, Marcel W
Musters, Annelie H
Post, Nicoline F
Bosma, Angela L
Hilhorst, Marc L
Vegting, Yosta
Bemelman, Frederike J
Voskuyl, Alexandre E
Broens, Bo
Sanchez, Agner Parra
van Els, Cécile A C M
de Wit, Jelle
Rutgers, Abraham
de Leeuw, Karina
Horváth, Barbara
Verschuuren, Jan J G M
Ruiter, Annabel M
van Ouwerkerk, Lotte
van der Woude, Diane
Allaart, Renée C F
Teng, Y K Onno
van Paassen, Pieter
Busch, Matthias H
Jallah, Papay B P
Brusse, Esther
van Doorn, Pieter A
Baars, Adája E
Hijnen, Dirk Jan
Schreurs, Corine R G
van der Pol, W Ludo
Goedee, H Stephan
Keijzer, Sofie
Keijser, Jim B D
Boogaard, Arend
Cristianawati, Olvi
Ten Brinke, Anja
Verstegen, Niels J M
Zwinderman, Koos A H
van Ham, S Marieke
Kuijpers, Taco W
Rispens, Theo
Eftimov, Filip
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.Published in
The Lancet. Rheumatology 2022; 4(5):e338-e350PMID
35317410ae974a485f413a2113503eed53cd6c53
10.1016/S2665-9913(22)00034-0
Scopus Count
Collections
Related articles
- Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
- Authors: Boekel L, Stalman EW, Wieske L, Hooijberg F, van Dam KPJ, Besten YR, Kummer LYL, Steenhuis M, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D'Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Parra Sanchez A, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, van der Pol WL, Goedee HS, Vogelzang EH, Leeuw M, Atiqi S, van Vollenhoven R, Gerritsen M, van der Horst-Bruinsma IE, Lems WF, Nurmohamed MT, Boers M, Keijzer S, Keijser J, van de Sandt C, Boogaard A, Cristianawati O, Ten Brinke A, Verstegen NJM, Zwinderman KAH, van Ham SM, Rispens T, Kuijpers TW, Wolbink G, Eftimov F, T2B! immunity against SARS-CoV-2 study group
- Issue date: 2022 Jun
- Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators.
- Authors: Sabatino JJ Jr, Mittl K, Rowles W, Zamecnik CR, Loudermilk RP, Gerungan C, Spencer CM, Sagan SA, Alexander J, Mcpolin K, Chen P, Deshpande C, Wyse K, Maiese EM, Wilson MR, Zamvil SS, Bove R
- Issue date: 2023 Feb
- Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies.
- Authors: Boekel L, Steenhuis M, Hooijberg F, Besten YR, van Kempen ZLE, Kummer LY, van Dam KPJ, Stalman EW, Vogelzang EH, Cristianawati O, Keijzer S, Vidarsson G, Voskuyl AE, Wieske L, Eftimov F, van Vollenhoven R, Kuijpers TW, van Ham SM, Tas SW, Killestein J, Boers M, Nurmohamed MT, Rispens T, Wolbink G
- Issue date: 2021 Nov
- Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes.
- Authors: Holroyd KB, Healy BC, Conway S, Houtchens M, Bakshi R, Bhattacharyya S, Bose G, Galetta K, Kaplan T, Severson C, Singhal T, Stazzone L, Zurawski J, Polgar-Turcsanyi M, Saxena S, Paul A, Glanz BI, Weiner HL, Chitnis T
- Issue date: 2022 Nov
- Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study.
- Authors: Moor MB, Suter-Riniker F, Horn MP, Aeberli D, Amsler J, Möller B, Njue LM, Medri C, Angelillo-Scherrer A, Borradori L, Radonjic-Hoesli S, Seyed Jafari SM, Chan A, Hoepner R, Bacher VU, Mani LY, Iype JM, Hirzel C, Maurer B, Sidler D
- Issue date: 2021 Nov